NEW YORK (GenomeWeb News) – Absorption Systems of Exton, Pa. has won a grant from the US Food and Drug Administration to continue developing its line of cell-based tests to measure drug interactions in humans, the company said today.

The $417,000 Phase II Small Business Innovation Research grant will fund the development of the CellPort Technologies suite of in vitro test systems. These tests are designed to monitor interactions of drugs with a class of proteins called drug transporters, which mediate drug disposition throughout the body.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.